Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-388P encodes a processed pseudogene corresponding to U6 small nuclear RNA, one of many U6-related pseudogenes present in the human genome[4][5]. Unlike functional U6 snRNA, which is a core component of the spliceosome (the molecular machine responsible for removing introns from pre-mRNA in eukaryotes)[1][3], RNU6-388P does not produce a functional RNA product and does not participate in pre-mRNA splicing. Pseudogenes are generally regarded as evolutionary remnants and typically lack biological function, though some pseudogenes can exert regulatory effects by producing non-coding RNAs that influence gene expression or act as molecular sponges for microRNAs[6]. There is currently no evidence to suggest that RNU6-388P itself is transcribed or has such regulatory activity. It is not considered a therapeutic target, enzyme, transporter, or receptor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 388, pseudogene (RNU6-388P).